ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS
SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ — ImmunoForge announced that it…
January 14, 2025
DJI Launches All-in-One Vlog Camera Drone with DJI Flip
New DJI Flip is DJI’s first drone to feature foldable, full-coverage propeller…
January 14, 2025
Triller Downloads Skyrocket Ahead of TikTok Ban
LOS ANGELES, Jan. 14, 2025 /PRNewswire/ — Triller, a creator-focused social media…